Tag Archives: Drug

Third Akorn sterile drug plant hit by FDA as new CEO lays out blueprint for a better future

Akorn Pharmaceuticals, which had a $ 4.3 billion buyout by Fresenius tank last fall, just can’t seem to catch a break. Just weeks after being hit with an FDA warning letter for its manufacturing operations in Illinois—problems that led to the death of the deal—Akorn today reported that it has received a citation on its third… Read More »

Drug May Be Safer Option Against Repeat Stroke

By Robert Preidt HealthDay Reporter THURSDAY, Feb. 7, 2019 (HealthDay News) — Taking the blood thinner Pletal (cilostazol) with either aspirin or clopidogrel (best known as Plavix) lowers stroke patients’ risk of a subsequent stroke better than taking aspirin or clopidogrel alone, a new study finds. The Japanese study was funded by Pletal’s maker, Otsuka… Read More »

Drug monitoring platform to help Maryland combat opioids

The State of Maryland is getting new software to collect information about controlled substances dispensed in the state to facilitate better data sharing. The RxGov prescription drug monitoring platform, from NIC, provides near real-time data that will integrate with the Chesapeake Regional Information System for our Patients (CRISP), the state health information exchange. Data also… Read More »

Health and Human Services wants to end 'middlemen kickbacks' in drug pricing by targeting rebates

HHS Secretary Alex Azar The Department of Health and Human Services is proposing to lower the list price of prescription drugs by correcting what it calls the perverse incentive to increase list prices to get higher rebates. The rebates are passed on to health plans, which use them to lower the price of premiums. But… Read More »

ANOTHER Alzheimer's drug fails: Trials of an experimental treatment cancelled two years early

ANOTHER Alzheimer’s drug fails: Trials of a highly-anticipated experimental treatment cancelled two years early Drugmaker Roche has cancelled two clinical trials of an experimental Alzheimer’s drug, crenezumab  The pair of trials join over 100 failed Alzheimer’s trials  Crenezumab was thought to target harmful protein plaques in the brains of early-stage dementia sufferers But the patients’… Read More »